机构地区:[1]新疆医科大学基础医学院人体解剖学教研室,乌鲁木齐830011 [2]新疆医科大学第一临床学院,乌鲁木齐830011
出 处:《中国性科学》2021年第9期1-4,共4页Chinese Journal of Human Sexuality
基 金:国家自然科学基金(81860781);新疆医科大学第13期大学生创新训练计划(CX2018074)。
摘 要:目的研究伊木萨克对复合应激勃起功能障碍(ED)大鼠模型阴茎组织中法尼酯X受体/含黄素单加氧酶3/氧化三甲胺(FXR/FMO3/TMAO)脂代谢通路的影响,并探讨其调控机制。方法选取2018年9月购自新疆医科大学实验动物中心的150只6周龄的雄性Sprag-Dawley大鼠作为研究对象。采用酶联免疫吸附试验法检测TMAO在正常对照组(n=30)、复合应激ED组(n=30)和伊木萨克给药组(n=30)血清中的浓度;采用免疫组化法检测FMO3、FXR1/2在三组阴茎组织中表达水平的变化。结果①复合应激ED组血清中TMAO浓度为(44.59±5.86)μg/mL,较正常对照组的(32.38±4.27)μg/mL升高37.71%,差异具有统计学意义(P<0.001);伊木萨克给药组血清中TMAO浓度为(37.68±4.15)μg/mL,较复合应激ED组下降16.37%,差异具有统计学意义(P<0.001)。②复合应激ED组阴茎组织中FMO3表达水平为(166.31±59.43),较正常对照组的(63.45±17.97)升高162.30%,差异具有统计学意义(P<0.001);伊木萨克给药组阴茎组织中FMO3表达水平为(78.53±65.69),较复合应激ED组降低52.78%,差异具有统计学意义(P<0.001)。③复合应激ED组阴茎组织中FXR1表达水平为(73.51±29.50),较正常对照组的(26.98±13.52)升高172.46%,差异具有统计学意义(P<0.001);伊木萨克给药组阴茎组织中FXR1表达水平为(44.64±14.37),较复合应激ED组降低39.27%,差异具有统计学意义(P<0.001)。复合应激ED组大鼠阴茎组织FXR2表达水平为(63.53±23.40),较正常对照组的(38.56±11.42)升高64.76%,差异具有统计学意义(P<0.001);伊木萨克给药组大鼠阴茎组织FXR2表达水平为(48.65±15.31),较复合应激ED组降低23.42%,差异具有统计学意义(P<0.001)。结论伊木萨克可抑制复合应激ED大鼠模型中FXR/FMO3/TMAO脂代谢通路的活化,对ED大鼠起到保护作用,其作用机制可能涉及抗氧化、降血脂作用。Objective To study the effect of Yimusake on the farnesoid X receptor/flavin-containing monooxygenase 3/trimethylamine-N-oxide(FXR/FMO3/TMAO)lipid metabolism pathway in penile tissue of the rat model of erectile dysfunction(ED)with complex stress,and explore its regulation mechanism.Methods 1506-week-old male Sprag-Dawley rats purchased from the Experimental Animal Center of Xinjiang Medical University in September 2018 were selected as the research objects.The serum concentrations of TMAO in normal control group(n=30),compound stress ED group(n=30)and Yimusake intervention group(n=30)were determined by enzyme-linked immunosorbent assay.The expression levels of FMO3 and FXR1/2 in penile tissues of the three groups were detected by immunohistochemistry.Results(1)The concentration of serum TMAO in the compound stress ED group(44.59±5.86)μg/mL was 37.71% higher than that in the normal control group(32.38±4.27)μg/mL(P<0.001).The serum TMAO concentration in the Yimusake intervention group(37.68±4.15)μg/mL was 16.37% lower than that in the compound stress ED group(P<0.001).(2)FMO3 expression in the penis was increased in the compound stress ED group(166.31±59.43)than the normal control group(63.45±17.97)by 162.30%(P<0.001).FMO3 expression in the penis was decreased in the Yimusake intervention group(78.53±65.69)than the compound stress ED group by 52.78%(P<0.001).(3)FXR1 expression in the penis was increased in the compound stress ED group(73.51±29.50)than the normal control group(26.98±13.52)by 172.46%(P<0.001).FXR1 expression in the penis was decreased in the Yimusake intervention group(44.64±14.37)than the compound stress ED group by 39.27%(P<0.001).FXR2 expression in the penis was increased in the compound stress ED group(63.53±23.40)than the normal control group(38.56±11.42)by 64.76%(P<0.001).FXR2 expression in the penis was decreased in the Yimusake intervention group(48.65±15.31)than ED group by 23.42%(P<0.001).Conclusions Yimusake can inhibit the activation of FXR/FMO3/TMAO lipid metabolism pathw
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...